Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page header. This appears to be a site version update with no changes to study data or user-facing content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe version history now lists Revision: v3.4.2 and removes Revision: v3.4.1. This reflects a minor site revision in the history log.SummaryDifference0.0%

- Check43 days agoChange DetectedA new revision entry v3.4.1 was added to the record history, replacing the previous v3.4.0 entry.SummaryDifference0.0%

- Check50 days agoChange DetectedRecord History now shows a glossary toggle, green highlights for additions, red highlights for deletions, and an updated revision label (v3.4.0).SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision v3.3.4 was added to the Record History, and revision v3.3.3 was removed.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page history adds a new site revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.